Under the 2014 Pharmaceutical Price Regulation Scheme (PPRS), scheme members make payments to the Department based on the difference between allowed percentage growth rate and actual percentage growth rate in National Health Service expenditure on branded medicines.
The 2014 PPRS has now delivered over £2.1 billion of PPRS payments.
Aggregate PPRS Payments
The Department receives the income on behalf of the United Kingdom, and then apportions the monies between the four countries. All funds are reinvested in health services for patient benefit.
Following normal Government accounting rules, there is no separately identified or ring-fenced funding stream associated with PPRS payments.